AA-Xylazine, 20 mg/ml oplossing voor injectie voor honden en katten
AA-Xylazine, 20 mg/ml oplossing voor injectie voor honden en katten
Authorised
- Xylazine hydrochloride
Product identification
Medicine name:
AA-Xylazine, 20 mg/ml oplossing voor injectie voor honden en katten
Active substance:
- Xylazine hydrochloride
Target species:
-
Dog
-
Cat
Route of administration:
-
Intramuscular use
-
Intravenous use
-
Subcutaneous use
Product details
Active substance and strength:
-
Xylazine hydrochloride20.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Dog
-
Cat
-
-
Intravenous use
-
Dog
-
Cat
-
-
Subcutaneous use
-
Dog
-
Cat
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN05CM92
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Netherlands
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Informed consent application (Article 13c of Directive No 2001/82/EC)
Marketing authorisation holder:
- A.A.-Vet Diergeneesmiddelen N.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Produlab Pharma B.V.
Responsible authority:
- Medicines Evaluation Board
Authorisation number:
- REG NL 113340
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Dutch (PDF)
Published on: 26/11/2024
How useful was this page?:
